col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


53 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Stem Cell Research & Therapy
  original article Date Title Authors   All Authors
1 [GO] 2026―Jun―15 MSCs/EVs-based therapy targeting DAD: research progress and future perspectives from ARDS and COVID-19 to RP-ILD Xiangzhen Meng, Luo Wang, Xinlun Tian
2 [GO] 2026―May―11 Mesenchymal stem cell derived exosomes mitigate COVID-19 cytokine storm via Annexin A1 and TGF-β mediated MAPK pathway inhibition Nesrine Ebrahim, Hajir A. Al Saihati, Arigue A. Dessouky, Yasmeen Mohammed Ismail, Ashraf A. Shamaa, Shereen A. Mohamed, et al. (+5)
3 [GO] 2026―Apr―25 Therapeutic potential of mesenchymal stromal cells in COVID-19: a meta-analysis of clinical trials conducted since the pandemic onset Meng-Qi Yuan, Yue-Fei Pan, Zi-Ying Zhang, Ya-Xin Wu, Kai-Di Zhu, Ze-Rui Wang, et al. (+6)
4 [GO] 2025―Jul―01 Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein Anna Pezzotta, Alessandra Bovio, Barbara Imberti, Monica Locatelli, Daniela Corna, Domenico Cerullo, et al. (+5)
5 [GO] 2025―May―14 Lyophilized MSC-EVs attenuates COVID-19 pathogenesis by regulating the JAK/STAT pathway Nesrine Ebrahim, Hajir A. Al Saihati, Zahraa Alali, Sabry Younis Mohamed Mahmoud, Ali A. Rabaan, Arigue A. Dessouky, et al. (+8)
6 [GO] 2025―Feb―25 Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial Meng-Qi Yuan, Le Song, Ze-Rui Wang, Zi-Ying Zhang, Ming Shi, Junli He, et al. (+21)
7 [GO] 2025―Jan―23 Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection Kátia Nunes da Silva, Fernanda Martins Marim, Gisele Vieira Rocha, Zaquer Suzana Munhoz Costa-Ferro, Luciana Souza de Aragão França, Carolina Kymie Vasques Nonaka, et al. (+13)
8 [GO] 2024―Oct―16 Correction: MSC-extracellular vesicle microRNAs target host cell-entry receptors in COVID-19: in silico modeling for in vivo validation Hajer A. Al Saihati, Arigue A. Dessouky, Rabab F. Salim, Islam Elgohary, Mohamed El-Sherbiny, Fares E. M. Ali, et al. (+5)
9 [GO] 2024―Sep―20 MSC-extracellular vesicle microRNAs target host cell-entry receptors in COVID-19: in silico modeling for in vivo validation Hajer A. Al Saihati, Arigue A. Dessouky, Rabab F. Salim, Islam Elgohary, Mohamed El-Sherbiny, Fares E. M. Ali, et al. (+5)
10 [GO] 2024―Aug―13 Characteristics of HPC(A) product obtained from a donor with SARS-CoV-2 infection and outcome of autologous transplant Pranav S. Renavikar, Phyllis I. Warkentin, Shelly M. Williams, Krishna Gundabolu, Charles Branson, Scott A. Koepsell
11 [GO] 2024―Apr―19 Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life Alexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, Jean-Luc Diehl, et al. (+33)
12 [GO] 2023―Dec―12 SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts Xiao Li, Hengrui Hu, Wanlin Liu, Qiyu Zhang, Yujie Wang, Xingjuan Chen, et al. (+5)
13 [GO] 2023―Dec―10 Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19 Tian-Tian Li, Wei-Qi Yao, Hai-Bo Dong, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, et al. (+2)
14 [GO] 2023―Nov―06 Cell-based passive immunization for protection against SARS-CoV-2 infection Evan Sawula, Shane Miersch, Eric D. Jong, Chengjin Li, Fang-Yu Chou, Jean Kit Tang, et al. (+4)
15 [GO] 2023―Sep―13 SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes Juli Liu, Shiyong Wu, Yucheng Zhang, Cheng Wang, Sheng Liu, Jun Wan, Lei Yang
16 [GO] 2023―Jun―26 Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, Faezeh Shekari, Seyedeh-Esmat Hosseini, Seyed-Mohammad Reza Hashemian, et al. (+16)
17 [GO] 2023―May―04 Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials Qinxue Liu, Fengjie Ma, Yizhi Zhong, Gaojian Wang, Li Hu, Yaping Zhang, Junran Xie
18 [GO] 2023―Apr―28 The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy Toka A. Ahmed, Bassant Eldaly, Shadwa Eldosuky, Hoda Elkhenany, Azza M. El-Derby, Muhamed F. Elshazly, Nagwa El-Badri
19 [GO] 2023―Apr―18 The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study Dat Ngo, Jason Chen, Jose Tinajero, Ahmed Aribi, Shukaib Arslan, Guido Marcucci, et al. (+5)
20 [GO] 2022―Aug―12 Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment Yuling Huang, Xin Li, Lina Yang
21 [GO] 2022―Jul―28 Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment Hamid Reza Aghayan, Fatemeh Salimian, Atefeh Abedini, Samrand Fattah Ghazi, Masud Yunesian, Sepideh Alavi-Moghadam, et al. (+12)
22 [GO] 2022―Jul―16 One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment Lei Shi, You Zheng, Zhi Cheng, Ningfei Ji, Changming Niu, Yan Wang, et al. (+12)
23 [GO] 2022―Jun―28 Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani, Amir Adhami Moghadam, Ahmad Bagheri Moghadam, Nayereh Khadem Ghaebi, et al. (+4)
24 [GO] 2022―Jun―17 Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19 Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Omid Gholizadeh, Hamed Rahmani Youshanlouei, Saeed Karimi Matloub, et al. (+4)
25 [GO] 2022―May―26 Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study Ying-Gang Zhu, Meng-meng Shi, Antoine Monsel, Cheng-xiang Dai, Xuan Dong, Hong Shen, et al. (+9)
26 [GO] 2022―Apr―01 Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial Muhammad Karyana, Irawaty Djaharuddin, Lutfah Rif’ati, Mansyur Arif, Mi Kyung Choi, Nova Angginy, et al. (+8)
27 [GO] 2022―Mar―25 Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation Amirhesam Babajani, Kasra Moeinabadi-Bidgoli, Farnaz Niknejad, Hamidreza Rismanchi, Sepehr Shafiee, Siavash Shariatzadeh, et al. (+3)
28 [GO] 2022―Mar―24 Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives Weiqi Yao, Lei Shi, Yun Zhang, Haibo Dong, Yu Zhang
29 [GO] 2022―Mar―21 Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial Carmen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Claudio Luciano Franck, Debora Regina Daga, Patrícia Shigunov, Marco Augusto Stimamiglio, et al. (+13)
30 [GO] 2022―Mar―21 Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention Yan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, Camille Carmona, Yang Zhou, Derek Lee, et al. (+6)
31 [GO] 2022―Mar―07 Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II Mina Fathi-Kazerooni, Samrand Fattah-Ghazi, Maryam Darzi, Jalil Makarem, Reza Nasiri, Faeze Salahshour, et al. (+2)
32 [GO] 2022―Feb―07 Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19 Kun Lu, Shi-tao Geng, Shikai Tang, Hua Yang, Wei Xiong, Fang Xu, et al. (+8)
33 [GO] 2022―Jan―15 Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury Ramana Vaka, Saad Khan, Bin Ye, Yousef Risha, Sandrine Parent, David Courtman, et al. (+2)
34 [GO] 2022―Jan―10 When stem cells meet COVID-19: recent advances, challenges and future perspectives Shasha Li, Hecheng Zhu, Ming Zhao, Weidong Liu, Lei Wang, Bin Zhu, et al. (+6)
35 [GO] 2021―Aug―21 Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects Mai Abdelgawad, Nourhan Saied Bakry, Ahmed A. Farghali, Ahmed Abdel-Latif, Ahmed Lotfy
36 [GO] 2021―Jul―27 Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19? Kátia Nunes da Silva, André Luiz Nunes Gobatto, Zaquer Suzana Munhoz Costa-Ferro, Bruno Raphael Ribeiro Cavalcante, Alex Cleber Improta Caria, Luciana Souza de Aragão França, et al. (+5)
37 [GO] 2021―Jul―16 Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial Mahshid Saleh, Amir Abbas Vaezi, Rasoul Aliannejad, Amir Ali Sohrabpour, Seyedeh Zahra Fotook Kiaei, Mahdi Shadnoush, et al. (+8)
38 [GO] 2021―Jul―15 Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction Anahid Safari, Vicenzo Lionetti, Iman Razeghian-Jahromi
39 [GO] 2021―Jun―02 The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia Rachele Ciccocioppo, Davide Gibellini, Giuseppe Astori, Martina Bernardi, Angela Bozza, Katia Chieregato, et al. (+16)
40 [GO] 2021―May―12 Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era Birbal Singh, Gorakh Mal, Vinod Verma, Ruchi Tiwari, Muhammad Imran Khan, Ranjan K. Mohapatra, et al. (+5)
41 [GO] 2021―Mar―01 Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus? Rodrigo N. Riedel, Antonio Pérez-Pérez, Víctor Sánchez-Margalet, Cecilia L. Varone, Julieta L. Maymó
42 [GO] 2021―Jan―29 Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi, Masoud Soleimani, Massoud Vosough, Seyedeh-Esmat Hosseini, et al. (+19)
43 [GO] 2021―Jan―04 Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19 Loubna Mazini, Mohamed Ezzoubi, Gabriel Malka
44 [GO] 2020―Nov―30 Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells Youjeong Kwon, Sarath Babu Nukala, Shubhi Srivastava, Hiroe Miyamoto, Nur Izzah Ismail, Jordan Jousma, et al. (+4)
45 [GO] 2020―Oct―15 Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients Sara Al-Khawaga, Essam M. Abdelalim
46 [GO] 2020―Sep―18 The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm Maria Kavianpour, Mahshid Saleh, Javad Verdi
47 [GO] 2020―Aug―18 Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells Lei Shu, Changming Niu, Ruyou Li, Tingrong Huang, Yan Wang, Mao Huang, et al. (+11)
48 [GO] 2020―Aug―14 Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia Ali Akbari, Jafar Rezaie
49 [GO] 2020―Jul―22 Mesenchymal stem cells: current clinical progress in ARDS and COVID-19 Kun Xiao, Fei Hou, Xiuyu Huang, Binbin Li, Zhi Rong Qian, Lixin Xie
50 [GO] 2020―Jul―16 A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report Hongbing Peng, Tiefeng Gong, Xiaoying Huang, Xun Sun, Hong Luo, Weizhong Wang, et al. (+9)
51 [GO] 2020―May―27 Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia Yingxin Zhang, Jie Ding, Shaoda Ren, Weihua Wang, Yapei Yang, Shuangjing Li, et al. (+7)
52 [GO] 2020―May―24 Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury Jiang Du, Han Li, Jie Lian, Xinxing Zhu, Liang Qiao, Juntang Lin
53 [GO] 2020―May―04 Mesenchymal stem cells as a potential therapy for COVID-19 Shan Liu, Danyi Peng, Huijun Qiu, Ke Yang, Zhou Fu, Lin Zou
 [1] 

53 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec